Passive and active biosensing with nucleic acid-protein hybrid nanostructures.

Advanced profiling of multiple biomarkers can individualize patient characterization and empower precision medicine. Conventional diagnostic methods, however, often require extensive processing and lack assay versatility and/or multiplexing capacity…

Preview only. Read the full abstract at the source